KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

YOHUMATE CAPSULES

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

 

GENERIC NAME:

YOHUMBINE

 

MANUFACTURER:

21 ST CENTURY

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

(none)

 

INDICATIONS:

Erectile dysfunction

Mydriasis

 

SIDE EFFECTS:

Increased blood pressure

increased heart rate

Dizziness

headache

irritability

nervousness or restlessness

Nausea or vomiting

skin flushing

sweating

tremor

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Depression

Psychiatric illness, other

Hepatic function impairment

 

ADULT DOSE:

[Impotence] - Oral, 5.4 to 6 mg three times a day. Note: If side effects occur, dosage may be reduced in half, followed by gradual increases. A dose of 10 mg three times a day may be appropriate in some patients; however, the incidence of side effects may be increased.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

[Impotence] - Oral, 5.4 to 6 mg three times a day. Note: If side effects occur, dosage may be reduced in half, followed by gradual increases. A dose of 10 mg three times a day may be appropriate in some patients; however, the incidence of side effects may be increased. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT